Featured Articles

Ask the OB-GYN | Shape | Find Artic...

Q I've heard of stress suppressing your period, but can it also do the opposite and make it come about twice a month o...

Try C for the Big C

Because of its popularity and widespread use as a dietary supplement, Vitamin C may be more familiar to the general pub...

Hismanal eyes Seldane's antihistami...

Hismanal eyes Seldane's antihistamine market share

Gerd Treatment – Know the Facts

H-2-receptor blockers. Over-the-counter H-2-receptor blockers, such as cimetidine (Tagamet HB), famotidine (Pepcid AC)...

Behcets Disease - Prevention Tips a...

Behcets Disease - Prevention Tips and Treatment Methods Behçet disease is a chronic condition due to dist...

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

Drug Information Related to Abacavir Sulfate

Back

01. ABACAVIR (Ziagen). - Free Online Library

Abacavir abacavir /abac·a·vir/ (ah-bak´ah-vir) a nonnucleoside reverse transcriptase inhibitor used as the sulfate salt as an antiretroviral in the treatment of human immunodeficiency virus infection. tablets are yellow, capsule-shaped, film-coated and i...

02. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg...

-- Once Granted by the European Commission, ATRIPLA Would Represent the First And Only Once-Daily Single Tablet Regimen for Many HIV/AIDS Patients in the European Union -- PRINCETON, N.J. & FOSTER CITY, Calif. & WHITEHOUSE STATION, N.J. -- Bristol-Myer...

03. 144-Week Data from Gilead's Study 934 Comparing Truvada(R) to Combivir...

SYDNEY, Australia -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced the presentation of 144-week data from an ongoing clinical trial, Study 934, comparing a once-daily regimen of Truvada([R]) (emtricitabine and tenofovir disoproxil fumarate) and Sustiva([R])...

04. Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To...

-- Results From Phase III 'SWEET' Study Presented at the 11(th) European AIDS Conference -- FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced 48-week data from a Phase III clinical trial evaluating virologically-suppressed patients wit...

05. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabin...

Product Developed Through Joint Venture Between Bristol-Myers Squibb and Gilead Sciences, the First of Its Kind in HIV Treatment PRINCETON, N.J. & FOSTER CITY, Calif. -- The European Commission has granted marketing authorization for ATRIPLA([R] )(efaviren...

06. Human drugs. - Free Online Library

12333W Dental Resources, Inc., Delano, MN, March 11 (Minneapolis). FDA stated that the firm's Home Care Stannous Gel (0.4% stannous fluoride treatment gel) needs to be marketed as an over-the-counter (OTC) drug according to a 1995 final regulation governing th...

07. Out of the laboratory and into the bathroom cabinet: designing and ......

Overview ...

08. New drugs 99, part III | Nursing | Find Articles at BNET.com

The drugs I'll examine this month include: ...

09. Aurobindo Pharma's | Drug Store News | Find Articles at BNET.com

Aurobindo Pharma's generic abacavir sulfate tablets have received tentative approval from the FDA. These are the first generic version of Ziagent Tablets, an anti-HIV medication from GlaxoSmithKline. The new generic will now be available for purchase under the Preside...

10. FDA panel recommends agency OK of Ziagen for HIV therapy | Drug Store ...

A Food and Drug Administration advisory panel has recommended accelerated approval of Glaxo Wellcome Inc.'s Ziagen (abacavir sulfate), a nucleoside analogue reverse transcriptase inhibitor for the treatment of HIV. The Antiviral 9rugs Advisory Committee voted to recom...

11. Drug challenge | Nursing | Find Articles at BNET.com

You routinely administer combination drugs...but do you know what's in them? To find out, match each combination of ingredients in Section II with its correct name in Section I. ...

12. Out of the laboratory and into the bathroom cabinet: designing and ......

Overview ...

13. Two separate tampering alerts issued | Nursing | Find Articles at BNET...

ZYPREXA, ZIAGEN ...

14. Treatment options for HIV, AIDS | FDA Consumer | Find Articles at BNET...

New drug combinations to attack HIV, the virus that causes AIDS, and an injectable product to correct facial fat loss have been added to the list of approved treatments for people with HIV. ...

15. Fake, mislabeled drugs hit four drug makers - Chain Pharmacy - Brief ....

NEW YORK - At least four prescription drug products were the subject of tampering or counterfeiting last month, putting the Food and Drug Administration, pharmacists and patients on alert. ...